Reduced expression of the ROCK inhibitor Rnd3 is associated with increased invasiveness and metastatic potential in mesenchymal tumor cells.

<h4>Background</h4>Mesenchymal and amoeboid movements are two important mechanisms adopted by cancer cells to invade the surrounding environment. Mesenchymal movement depends on extracellular matrix protease activity, amoeboid movement on the RhoA-dependent kinase ROCK. Cancer cells can...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Cristina Belgiovine, Roberta Frapolli, Katiuscia Bonezzi, Ilaria Chiodi, Francesco Favero, Maurizia Mello-Grand, Angelo P Dei Tos, Elena Giulotto, Giulia Taraboletti, Maurizio D'Incalci, Chiara Mondello
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2010
Materias:
R
Q
Acceso en línea:https://doaj.org/article/ab26f552175c4a31926a567953d3f219
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:ab26f552175c4a31926a567953d3f219
record_format dspace
spelling oai:doaj.org-article:ab26f552175c4a31926a567953d3f2192021-11-18T07:02:12ZReduced expression of the ROCK inhibitor Rnd3 is associated with increased invasiveness and metastatic potential in mesenchymal tumor cells.1932-620310.1371/journal.pone.0014154https://doaj.org/article/ab26f552175c4a31926a567953d3f2192010-11-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21209796/?tool=EBIhttps://doaj.org/toc/1932-6203<h4>Background</h4>Mesenchymal and amoeboid movements are two important mechanisms adopted by cancer cells to invade the surrounding environment. Mesenchymal movement depends on extracellular matrix protease activity, amoeboid movement on the RhoA-dependent kinase ROCK. Cancer cells can switch from one mechanism to the other in response to different stimuli, limiting the efficacy of antimetastatic therapies.<h4>Methodology and principal findings</h4>We investigated the acquisition and molecular regulation of the invasion capacity of neoplastically transformed human fibroblasts, which were able to induce sarcomas and metastases when injected into immunocompromised mice. We found that neoplastic transformation was associated with a change in cell morphology (from fibroblastic to polygonal), a reorganization of the actin cytoskeleton, a decrease in the expression of several matrix metalloproteases and increases in cell motility and invasiveness. In a three-dimensional environment, sarcomagenic cells showed a spherical morphology with cortical actin rings, suggesting a switch from mesenchymal to amoeboid movement. Accordingly, cell invasion decreased after treatment with the ROCK inhibitor Y27632, but not with the matrix protease inhibitor Ro 28-2653. The increased invasiveness of tumorigenic cells was associated with reduced expression of Rnd3 (also known as RhoE), a cellular inhibitor of ROCK. Indeed, ectopic Rnd3 expression reduced their invasive ability in vitro and their metastatic potential in vivo.<h4>Conclusions</h4>These results indicate that, during neoplastic transformation, cells of mesenchymal origin can switch from a mesenchymal mode of movement to an amoeboid one. In addition, they point to Rnd3 as a possible regulator of mesenchymal tumor cell invasion and to ROCK as a potential therapeutic target for sarcomas.Cristina BelgiovineRoberta FrapolliKatiuscia BonezziIlaria ChiodiFrancesco FaveroMaurizia Mello-GrandAngelo P Dei TosElena GiulottoGiulia TarabolettiMaurizio D'IncalciChiara MondelloPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 5, Iss 11, p e14154 (2010)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Cristina Belgiovine
Roberta Frapolli
Katiuscia Bonezzi
Ilaria Chiodi
Francesco Favero
Maurizia Mello-Grand
Angelo P Dei Tos
Elena Giulotto
Giulia Taraboletti
Maurizio D'Incalci
Chiara Mondello
Reduced expression of the ROCK inhibitor Rnd3 is associated with increased invasiveness and metastatic potential in mesenchymal tumor cells.
description <h4>Background</h4>Mesenchymal and amoeboid movements are two important mechanisms adopted by cancer cells to invade the surrounding environment. Mesenchymal movement depends on extracellular matrix protease activity, amoeboid movement on the RhoA-dependent kinase ROCK. Cancer cells can switch from one mechanism to the other in response to different stimuli, limiting the efficacy of antimetastatic therapies.<h4>Methodology and principal findings</h4>We investigated the acquisition and molecular regulation of the invasion capacity of neoplastically transformed human fibroblasts, which were able to induce sarcomas and metastases when injected into immunocompromised mice. We found that neoplastic transformation was associated with a change in cell morphology (from fibroblastic to polygonal), a reorganization of the actin cytoskeleton, a decrease in the expression of several matrix metalloproteases and increases in cell motility and invasiveness. In a three-dimensional environment, sarcomagenic cells showed a spherical morphology with cortical actin rings, suggesting a switch from mesenchymal to amoeboid movement. Accordingly, cell invasion decreased after treatment with the ROCK inhibitor Y27632, but not with the matrix protease inhibitor Ro 28-2653. The increased invasiveness of tumorigenic cells was associated with reduced expression of Rnd3 (also known as RhoE), a cellular inhibitor of ROCK. Indeed, ectopic Rnd3 expression reduced their invasive ability in vitro and their metastatic potential in vivo.<h4>Conclusions</h4>These results indicate that, during neoplastic transformation, cells of mesenchymal origin can switch from a mesenchymal mode of movement to an amoeboid one. In addition, they point to Rnd3 as a possible regulator of mesenchymal tumor cell invasion and to ROCK as a potential therapeutic target for sarcomas.
format article
author Cristina Belgiovine
Roberta Frapolli
Katiuscia Bonezzi
Ilaria Chiodi
Francesco Favero
Maurizia Mello-Grand
Angelo P Dei Tos
Elena Giulotto
Giulia Taraboletti
Maurizio D'Incalci
Chiara Mondello
author_facet Cristina Belgiovine
Roberta Frapolli
Katiuscia Bonezzi
Ilaria Chiodi
Francesco Favero
Maurizia Mello-Grand
Angelo P Dei Tos
Elena Giulotto
Giulia Taraboletti
Maurizio D'Incalci
Chiara Mondello
author_sort Cristina Belgiovine
title Reduced expression of the ROCK inhibitor Rnd3 is associated with increased invasiveness and metastatic potential in mesenchymal tumor cells.
title_short Reduced expression of the ROCK inhibitor Rnd3 is associated with increased invasiveness and metastatic potential in mesenchymal tumor cells.
title_full Reduced expression of the ROCK inhibitor Rnd3 is associated with increased invasiveness and metastatic potential in mesenchymal tumor cells.
title_fullStr Reduced expression of the ROCK inhibitor Rnd3 is associated with increased invasiveness and metastatic potential in mesenchymal tumor cells.
title_full_unstemmed Reduced expression of the ROCK inhibitor Rnd3 is associated with increased invasiveness and metastatic potential in mesenchymal tumor cells.
title_sort reduced expression of the rock inhibitor rnd3 is associated with increased invasiveness and metastatic potential in mesenchymal tumor cells.
publisher Public Library of Science (PLoS)
publishDate 2010
url https://doaj.org/article/ab26f552175c4a31926a567953d3f219
work_keys_str_mv AT cristinabelgiovine reducedexpressionoftherockinhibitorrnd3isassociatedwithincreasedinvasivenessandmetastaticpotentialinmesenchymaltumorcells
AT robertafrapolli reducedexpressionoftherockinhibitorrnd3isassociatedwithincreasedinvasivenessandmetastaticpotentialinmesenchymaltumorcells
AT katiusciabonezzi reducedexpressionoftherockinhibitorrnd3isassociatedwithincreasedinvasivenessandmetastaticpotentialinmesenchymaltumorcells
AT ilariachiodi reducedexpressionoftherockinhibitorrnd3isassociatedwithincreasedinvasivenessandmetastaticpotentialinmesenchymaltumorcells
AT francescofavero reducedexpressionoftherockinhibitorrnd3isassociatedwithincreasedinvasivenessandmetastaticpotentialinmesenchymaltumorcells
AT mauriziamellogrand reducedexpressionoftherockinhibitorrnd3isassociatedwithincreasedinvasivenessandmetastaticpotentialinmesenchymaltumorcells
AT angelopdeitos reducedexpressionoftherockinhibitorrnd3isassociatedwithincreasedinvasivenessandmetastaticpotentialinmesenchymaltumorcells
AT elenagiulotto reducedexpressionoftherockinhibitorrnd3isassociatedwithincreasedinvasivenessandmetastaticpotentialinmesenchymaltumorcells
AT giuliataraboletti reducedexpressionoftherockinhibitorrnd3isassociatedwithincreasedinvasivenessandmetastaticpotentialinmesenchymaltumorcells
AT mauriziodincalci reducedexpressionoftherockinhibitorrnd3isassociatedwithincreasedinvasivenessandmetastaticpotentialinmesenchymaltumorcells
AT chiaramondello reducedexpressionoftherockinhibitorrnd3isassociatedwithincreasedinvasivenessandmetastaticpotentialinmesenchymaltumorcells
_version_ 1718424063031902208